STOCK TITAN
  1. Home
  2. Sec-filings
  3. CVRX
  4. [Form 4] CVRx, Inc. Insider Trading Activity

CVRx (CVRX) director receives new share and stock option awards

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CVRx, Inc. director Kevin J. Ballinger reported receiving equity compensation consisting of common shares and stock options. He was granted 8,720 shares of Common Stock at no purchase price, bringing his direct common share holdings to 8,720 shares.

He was also granted a stock option for 11,182 shares of Common Stock at an exercise price of $5.43 per share, expiring on June 1, 2036. According to the footnote, this award vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders.

Positive

  • None.

Negative

  • None.
Insider Ballinger Kevin J.
Role null
Type Security Shares Price Value
Grant/Award Stock Option (right to buy) 11,182 $0.00 --
Grant/Award Common Stock 8,720 $0.00 --
Holdings After Transaction: Stock Option (right to buy) — 11,182 shares (Direct, null); Common Stock — 8,720 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Common stock grant 8,720 shares Common Stock awarded to director on June 1, 2026
Common shares held 8,720 shares Direct Common Stock holdings after the grant
Option grant size 11,182 shares Stock Option (right to buy) granted June 1, 2026
Option exercise price $5.43 per share Conversion or exercise price of stock option
Option expiration June 1, 2036 Expiration date of the stock option grant
Vesting date trigger June 1, 2027 Vests on earlier of this date or 2027 annual meeting
Stock Option (right to buy) financial
"Stock Option (right to buy) with 11,182 shares underlying Common Stock"
Grant, award, or other acquisition financial
"Transaction code A described as Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price of 5.4300 per share for the option"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vests financial
"Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ballinger Kevin J.
(Last)(First)(Middle)
9201 WEST BROADWAY AVE
SUITE 650
(Street)
MINNEAPOLIS MINNESOTA 55445
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
CVRx, Inc. [ CVRX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/01/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock06/01/2026A8,720(1)A$08,720D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy)$5.4306/01/2026A11,182 (1)06/01/2036Common Stock11,182$011,182D
Explanation of Responses:
1. Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.
/s/ Amy C. Seidel, Attorney-in-Fact06/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did CVRx (CVRX) report for Kevin J. Ballinger?

CVRx reported that director Kevin J. Ballinger received equity awards, including 8,720 shares of Common Stock and a stock option for 11,182 shares. These awards are compensation grants, not open-market purchases or sales, and were reported as acquisitions on the Form 4.

How many CVRx (CVRX) common shares did Kevin J. Ballinger receive?

Kevin J. Ballinger received 8,720 shares of CVRx Common Stock as a grant with a transaction price per share of $0.00. After this grant, his reported direct holdings of Common Stock total 8,720 shares, reflecting the newly awarded shares in his position.

What are the key terms of Kevin J. Ballinger’s CVRx stock option grant?

Ballinger received a stock option covering 11,182 shares of CVRx Common Stock at an exercise price of $5.43 per share. The option expires on June 1, 2036 and represents a right to buy shares rather than an immediate stock purchase transaction.

When do Kevin J. Ballinger’s CVRx equity awards vest?

According to the footnote, the equity award vests on the earlier of June 1, 2027 or the company’s 2027 annual meeting of stockholders. This vesting condition applies to the grant and determines when he fully earns the associated rights in the award.

Did Kevin J. Ballinger buy or sell CVRx (CVRX) shares on the open market?

No open-market buys or sells were reported. The Form 4 shows two acquisition transactions coded as grants or awards, one for Common Stock and one for a stock option, both with a transaction price per share of $0.00, indicating compensation-related awards.